Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% ...

The global women’s health diagnostics market is set to witness a growth rate of ~7% in the next 5 years. Increasing ...

MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life ...

Pharmaceutical scientists at the National University of Singapore (NUS) have developed a method that can measure the kinetic efficiency of an enzyme against more than 200,000 potential peptide ...

Every three seconds, one life is lost to sepsis, according to the Global Sepsis Alliance. It is a life-threatening, dysregulated immune response to infection and remains a leading cause of death ...

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

The key market opportunities in next-generation oncology devices include enhancing precision diagnostics and targeted treatments, leveraging AI & robotics, and integrating patient-centric models.

Researchers from the University of Birmingham's Bladder Cancer Research Center have used a new method to detect chemical ...

The non-coding genome, once dismissed as "junk DNA", is now recognized as a fundamental regulator of gene expression and a key player in understanding complex diseases. Following the landmark ...

Partnership delivers advanced reverse transcriptase technology to enhance sensitivity, robustness and reproducibility of ...

The Business Research Company’s Next Generation Tissue Biomarkers Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 / ...

Qiagen N.V. (NYSE:QGEN), a global leader in molecular diagnostics and sample preparation technologies, continues to advance ...